Zobrazeno 1 - 7 of 7 pro vyhledávání: '"D O Magro"'
1
P823 Biologic Penetration, hospitalization rates and need for major abdominal surgery in inflammatory bowel diseases: a comparative observational study between pediatric and adult patients
Autor: A C V Silva, T J Tumelero, D O Magro, D R Yamamoto, L B M Ribeiro, G S da Silva, S K Truppel, M C Vieira, P G Kotze MD- PhD
Publikováno v: Journal of Crohn's and Colitis. 17:i957-i958
Background There is lack of epidemiological data in regard to the accurate situation of Inflammatory Bowel Disease (IBD): Crohn’s disease (CD) and ulcerative colitis (UC) in Brazil. It is known that both diseases' progression is variable and the ch
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cb5f07ea97f4f8d2eeb04701bb8bc3a1
https://doi.org/10.1093/ecco-jcc/jjac190.0953
Zobrazit plný text záznamu
2
P586 Vedolizumab in Mild to Moderate Crohn's Disease Patients Naïve to Biological Therapy: a Multicentric Observational Study
Autor: A Z Dotti, E G Vilela, J M F Chebli, L A Chebli, D O Magro, F Steinwurz, M Argollo, N S Carvalho, J M L Parente, R S Parra, R L Perin, C Flores, E M Morsoletto, S D C Ferreira, J C Ludvig, R L Kaiser Jr, N S F Queiroz, M A G Faria, G M Nicollelli, A R Andrade, P G Kotze
Publikováno v: Journal of Crohn's and Colitis. 17:i714-i715
Background Vedolizumab, a human monoclonal antibody that blocks integrin α4-β7, was approved for the management of Inflammatory Bowel Diseases. In real-world experience the number of patients using vedolizumab as first-line biological therapy was l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d991fbf3781dc2731b42df83cb4dafbe
https://doi.org/10.1093/ecco-jcc/jjac190.0716
Zobrazit plný text záznamu
4
P459 Hospitalization, use of biologics and surgery rates in inflammatory bowel diseases: a single-center comparative analysis between public and private healthcare systems in a tertiary unit from Latin America
Autor: P Zacharias, M Perussolo, D O Magro, F D S B Barauna, P G Kotze
Publikováno v: Journal of Crohn's and Colitis. 17:i587-i587
Background Inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), characterized by chronic inflammation of the intestine, have a rising incidence and prevalence globally. The potential impact of socioeconomic inequality
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d868636afff60c57b549e247b7dc0d77
https://doi.org/10.1093/ecco-jcc/jjac190.0589
Zobrazit plný text záznamu
7
Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trial
Autor: M A, Tambascia, B, Geloneze, E M, Repetto, S R, Geloneze, M, Picolo, D O, Magro
Publikováno v: Diabetes, obesitymetabolism. 5(5)
To assess the effect of sibutramine-assisted weight reduction program on insulin sensitivity and metabolic parameters in obese normal glucose tolerant individuals over a period of 24 weeks.A double-blind, placebo-controlled, parallel, prospective cli
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eaaec4a69a5d24760be38202c20becb1
https://pubmed.ncbi.nlm.nih.gov/12940872
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje